Dalbavancin or oritavancin for skin infections

Comment

G Ralph Corey et al. N Engl J Med. 2014.

. 2014 Sep 18;371(12):1162-3.

doi: 10.1056/NEJMc1407925.

No abstract available

Comment on

Single-dose oritavancin in the treatment of acute bacterial skin infections.
Corey GR, Kabler H, Mehra P, Gupta S, Overcash JS, Porwal A, Giordano P, Lucasti C, Perez A, Good S, Jiang H, Moeck G, O'Riordan W; SOLO I Investigators. Corey GR, et al. N Engl J Med. 2014 Jun 5;370(23):2180-90. doi: 10.1056/NEJMoa1310422. N Engl J Med. 2014. PMID: 24897083 Clinical Trial.
Dalbavancin or oritavancin for skin infections.
Núñez-Núñez M, Rodríguez-Baño J. Núñez-Núñez M, et al. N Engl J Med. 2014 Sep 18;371(12):1160. doi: 10.1056/NEJMc1407925. N Engl J Med. 2014. PMID: 25229923 No abstract available.
Dalbavancin or oritavancin for skin infections.
Baang J, Fisher S. Baang J, et al. N Engl J Med. 2014 Sep 18;371(12):1160-1. doi: 10.1056/NEJMc1407925. N Engl J Med. 2014. PMID: 25229924 No abstract available.